Variant report

Variant	nsv581795
Chromosome Location	chr2:49380886-49429109
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:100)
CpG islands
(count:305)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:100 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr2:49381388-49381670	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr2:49426971-49427266	A549	lung:	n/a	chr2:49427145-49427158 chr2:49427145-49427156 chr2:49427146-49427157
3	CEBPB	chr2:49426968-49427294	HepG2	liver:	n/a	chr2:49427145-49427158 chr2:49427145-49427156 chr2:49427146-49427157
4	CEBPB	chr2:49389153-49389221	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr2:49397220-49397370	GM12872	blood:	n/a	n/a
6	CTCF	chr2:49397380-49397530	GM12870	blood:	n/a	n/a
7	CTCF	chr2:49397460-49397610	GM12874	blood:	n/a	n/a
8	CTCF	chr2:49397480-49397630	GM12872	blood:	n/a	n/a
9	CTCF	chr2:49426100-49426250	GM12867	blood:	n/a	n/a
10	CTCF	chr2:49397380-49397530	GM06990	blood:	n/a	n/a
11	CTCF	chr2:49397360-49397510	NB4	blood:	n/a	n/a
12	CTCF	chr2:49397440-49397590	GM12874	blood:	n/a	n/a
13	CTCF	chr2:49397460-49397610	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr2:49397420-49397570	GM12869	blood:	n/a	n/a
15	CTCF	chr2:49397494-49397639	GM19238	blood:	n/a	n/a
16	CTCF	chr2:49397512-49397615	MCF-7	breast:	n/a	n/a
17	CTCF	chr2:49397537-49397575	GM19240	blood:	n/a	n/a
18	CTCF	chr2:49397516-49397628	GM12878	blood:	n/a	n/a
19	CTCF	chr2:49382040-49382190	WI-38	lung:	n/a	n/a
20	CTCF	chr2:49397520-49397670	WERI-Rb-1	eye:	n/a	n/a
21	CTCF	chr2:49397524-49397650	MCF-7	breast:	n/a	n/a
22	CTCF	chr2:49397419-49397614	HepG2	liver:	n/a	n/a
23	CTCF	chr2:49397460-49397610	HEK293	kidney:	n/a	n/a
24	CTCF	chr2:49397540-49397690	HepG2	liver:	n/a	n/a
25	CTCF	chr2:49405083-49405153	Lung_OC	lung:	n/a	n/a
26	CTCF	chr2:49397440-49397730	GM12867	blood:	n/a	n/a
27	CTCF	chr2:49397518-49397623	MCF-7	breast:	n/a	n/a
28	CTCF	chr2:49397360-49397510	GM12875	blood:	n/a	n/a
29	CTCF	chr2:49397510-49397632	GM12891	blood:	n/a	n/a
30	CTCF	chr2:49397460-49397610	GM12872	blood:	n/a	n/a
31	CTCF	chr2:49397530-49397607	GM19239	blood:	n/a	n/a
32	CTCF	chr2:49397530-49397608	A549	lung:	n/a	n/a
33	CTCF	chr2:49397515-49397635	H1-hESC	embryonic stem cell:	n/a	n/a
34	E2F4	chr2:49422218-49422323	MCF10A-Er-Src	breast:	n/a	n/a
35	E2F4	chr2:49401066-49401266	MCF10A-Er-Src	breast:	n/a	n/a
36	ELK1	chr2:49389789-49389792	K562	blood:	n/a	n/a
37	EP300	chr2:49401399-49403252	SK-N-SH	brain:	n/a	chr2:49401932-49401945
38	EP300	chr2:49401880-49402234	SK-N-SH_RA	brain:	n/a	chr2:49401932-49401945
39	EP300	chr2:49404323-49404636	H1-hESC	embryonic stem cell:	n/a	n/a
40	EP300	chr2:49401917-49402257	SK-N-SH_RA	brain:	n/a	chr2:49401932-49401945
41	FAM48A	chr2:49414779-49414910	GM12878	blood:	n/a	n/a
42	FOS	chr2:49427010-49427231	MCF10A-Er-Src	breast:	n/a	n/a
43	FOS	chr2:49426973-49427262	MCF10A-Er-Src	breast:	n/a	n/a
44	FOS	chr2:49427015-49427299	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr2:49417123-49417302	MCF10A-Er-Src	breast:	n/a	chr2:49417151-49417158 chr2:49417149-49417158
46	FOS	chr2:49417093-49417336	MCF10A-Er-Src	breast:	n/a	chr2:49417151-49417158 chr2:49417149-49417158
47	FOXA1	chr2:49405635-49406064	HepG2	liver:	n/a	n/a
48	FOXA2	chr2:49413289-49413543	A549	lung:	n/a	n/a
49	GATA2	chr2:49401878-49402287	SH-SY5Y	brain:	n/a	n/a
50	GATA3	chr2:49404284-49404424	SH-SY5Y	brain:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:49382401-49382451	HCPEpiC	choroid plexus:	n/a
2	chr2:49382265-49382315	T-47D	breast:	n/a
3	chr2:49380959-49381009	AG10803	skin:	n/a
4	chr2:49381495-49381545	AG09319	gingival:	n/a
5	chr2:49380959-49381009	HRPEpiC	eye:	n/a
6	chr2:49382401-49382451	U87	brain:	n/a
7	chr2:49381495-49381545	HMEC	breast:	n/a
8	chr2:49382159-49382209	AG04450	lung:	fetal
9	chr2:49381495-49381545	HL-60	blood:	n/a
10	chr2:49382265-49382315	ovcar-3	ovarian:	n/a
11	chr2:49382265-49382315	BJ	skin:	n/a
12	chr2:49380959-49381009	HEEpiC	esophagus:	n/a
13	chr2:49382401-49382451	AG10803	skin:	n/a
14	chr2:49382159-49382209	U87	brain:	n/a
15	chr2:49382265-49382315	PANC-1	pancreas:	n/a
16	chr2:49380959-49381009	HMEC	breast:	n/a
17	chr2:49382159-49382209	NHBE	bronchial:	n/a
18	chr2:49381495-49381545	H1-hESC	embryonic stem cell:	embryo
19	chr2:49382159-49382209	Hepatocyte	liver:	n/a
20	chr2:49380959-49381009	GM06990	blood:	n/a
21	chr2:49382265-49382315	HRCEpiC	kidney:	n/a
22	chr2:49381495-49381545	K562	blood:	n/a
23	chr2:49380959-49381009	BJ	skin:	n/a
24	chr2:49380959-49381009	NH-A	brain:	n/a
25	chr2:49380959-49381009	AG04449	skin:	fetal
26	chr2:49381495-49381545	LNCaP	prostate:	n/a
27	chr2:49382401-49382451	ovcar-3	ovarian:	n/a
28	chr2:49382265-49382315	AG04449	skin:	fetal
29	chr2:49380959-49381009	T-47D	breast:	n/a
30	chr2:49382401-49382451	GM06990	blood:	n/a
31	chr2:49381495-49381545	HEEpiC	esophagus:	n/a
32	chr2:49381495-49381545	BJ	skin:	n/a
33	chr2:49381495-49381545	U87	brain:	n/a
34	chr2:49382401-49382451	BJ	skin:	n/a
35	chr2:49380959-49381009	MCF10A-Er-Src	breast:	n/a
36	chr2:49380959-49381009	U87	brain:	n/a
37	chr2:49382159-49382209	HAEpiC	amniotic membrane:	n/a
38	chr2:49382401-49382451	GM19239	blood:	n/a
39	chr2:49382401-49382451	SKMC	muscle:	n/a
40	chr2:49381495-49381545	SKMC	muscle:	n/a
41	chr2:49382159-49382209	HMEC	breast:	n/a
42	chr2:49382265-49382315	HepG2	liver:	n/a
43	chr2:49382265-49382315	AG10803	skin:	n/a
44	chr2:49381495-49381545	HCF	heart:	n/a
45	chr2:49382159-49382209	SK-N-SH	brain:	n/a
46	chr2:49382159-49382209	HCF	heart:	n/a
47	chr2:49382159-49382209	HL-60	blood:	n/a
48	chr2:49380959-49381009	SK-N-MC	brain:	n/a
49	chr2:49382159-49382209	NT2-D1	testis:	n/a
50	chr2:49382401-49382451	T-47D	breast:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:49394074..49396341-chr2:49397153..49398810,2	K562	blood:
2	chr2:49425509..49426338-chr3:115937869..115938784,2	MCF-7	breast:
3	chr2:49394074..49396341-chr2:49397153..49398810,2	K562	blood:

No data

Variant related genes	Relation type
FSHR	TF binding region
FSHR	CpG island

Extended variants
information (count: 1494 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:1494 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7572787	chr2:49380886-49380887	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs528335290	chr2:49380918-49380919	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs115365023	chr2:49380959-49380960	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs560703015	chr2:49380962-49380963	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs539465470	chr2:49380989-49380990	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs557419341	chr2:49380994-49380995	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs573208460	chr2:49380995-49380996	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs188515242	chr2:49380998-49380999	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs555563518	chr2:49381026-49381027	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs79896602	chr2:49381046-49381047	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs138336625	chr2:49381048-49381049	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs199608636	chr2:49381074-49381075	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs563038309	chr2:49381110-49381111	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs578000724	chr2:49381130-49381131	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs545396681	chr2:49381176-49381177	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs77417830	chr2:49381202-49381203	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs572756516	chr2:49381237-49381238	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs181433593	chr2:49381245-49381246	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs7589810	chr2:49381253-49381254	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs185266831	chr2:49381261-49381262	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs550497965	chr2:49381316-49381317	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs568935358	chr2:49381353-49381354	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs199766468	chr2:49381359-49381360	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs368337197	chr2:49381388-49381389	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs369583512	chr2:49381423-49381424	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs190096402	chr2:49381473-49381474	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs561684198	chr2:49381501-49381502	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs551113676	chr2:49381526-49381527	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs182046434	chr2:49381529-49381530	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs533522852	chr2:49381532-49381533	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs115030945	chr2:49381533-49381534	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs146918036	chr2:49381538-49381539	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs371608596	chr2:49381550-49381551	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs375033141	chr2:49381561-49381562	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs1394205	chr2:49381585-49381586	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs371875648	chr2:49381588-49381589	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs377105879	chr2:49381616-49381617	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs538437600	chr2:49381633-49381634	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs556441283	chr2:49381637-49381638	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs578059873	chr2:49381645-49381646	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs186151064	chr2:49381657-49381658	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs115357990	chr2:49381670-49381671	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs570574581	chr2:49381671-49381672	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs560548114	chr2:49381682-49381683	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs572510432	chr2:49381690-49381691	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs67177405	chr2:49381697-49381698	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs2882225	chr2:49381698-49381699	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs2349718	chr2:49381699-49381700	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs543035640	chr2:49381711-49381712	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs147264549	chr2:49381721-49381722	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:101 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:49379400-49381800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr2:49379800-49381200	Flanking Active TSS	HSMMtube	muscle
3	chr2:49380000-49381200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr2:49380000-49381200	Enhancers	HUES6 Cell Line	embryonic stem cell
5	chr2:49380000-49381400	Active TSS	Ovary	ovary
6	chr2:49380000-49382200	Enhancers	ES-I3 Cell Line	embryonic stem cell
7	chr2:49380000-49382200	Enhancers	HUES64 Cell Line	embryonic stem cell
8	chr2:49380000-49382400	Enhancers	HUES48 Cell Line	embryonic stem cell
9	chr2:49380000-49382600	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr2:49380200-49381200	Enhancers	Fetal Heart	heart
11	chr2:49380200-49382400	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr2:49380400-49381000	Active TSS	Fetal Muscle Leg	muscle
13	chr2:49380400-49381200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
14	chr2:49380400-49381400	Weak transcription	H9 Cell Line	embryonic stem cell
15	chr2:49380400-49381400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr2:49380400-49382400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr2:49380600-49381800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
18	chr2:49380600-49382200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr2:49381000-49381200	Weak transcription	Fetal Muscle Leg	muscle
20	chr2:49381200-49381400	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr2:49381200-49381400	Enhancers	HSMMtube	muscle
22	chr2:49381200-49381600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
23	chr2:49381200-49381600	Flanking Active TSS	Fetal Heart	heart
24	chr2:49381200-49381600	Enhancers	Fetal Muscle Leg	muscle
25	chr2:49381200-49381600	Active TSS	Right Atrium	heart
26	chr2:49381200-49382000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr2:49381400-49381600	Flanking Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr2:49381400-49381600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr2:49381400-49381600	Enhancers	Left Ventricle	heart
30	chr2:49381400-49381600	Flanking Active TSS	Ovary	ovary
31	chr2:49381400-49381600	Flanking Active TSS	HSMMtube	muscle
32	chr2:49381400-49382400	Enhancers	H9 Cell Line	embryonic stem cell
33	chr2:49381600-49382200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr2:49381600-49382200	Enhancers	Fetal Heart	heart
35	chr2:49381600-49382200	Enhancers	Ovary	ovary
36	chr2:49381600-49382400	Enhancers	HSMMtube	muscle
37	chr2:49381600-49382600	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr2:49381800-49382400	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr2:49382200-49382600	Enhancers	Breast Myoepithelial Primary Cells	Breast
40	chr2:49382400-49382600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr2:49387400-49388000	Enhancers	Fetal Muscle Leg	muscle
42	chr2:49387800-49390200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr2:49388000-49390400	Weak transcription	Fetal Muscle Leg	muscle
44	chr2:49389200-49389400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr2:49389200-49390000	Enhancers	HSMMtube	muscle
46	chr2:49389400-49389600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr2:49389400-49389800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr2:49389600-49390400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr2:49389800-49390000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr2:49390000-49391600	Weak transcription	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links